Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
British Journal of Cancer|December 1, 1995
Cytotoxic effect of RB 6145 in human tumour cell lines: dependence on hypoxia, extra- and intracellular pH and drug uptakeL D Skarsgard, D K Acheson, A Vinczan, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 8, 2008
Phase I/II study of a five-fraction hypofractionated accelerated radiotherapy treatment for low-risk localised prostate cancer: early results of pHART3C I Tang, D A Loblaw, P Cheung, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 18, 2008
A phase I/II study to evaluate the toxicity and efficacy of accelerated fractionation radiotherapy for the palliation of dysphagia from carcinoma of the oesophagusZ Kassam, R K S Wong, J Ringash, et al.
Journal of Translational Medicine|May 25, 2019
Circulating miRNAs as non-invasive biomarkers to predict aggressive prostate cancer after radical prostatectomyC Hoey, M Ahmed, A Fotouhi Ghiam, et al.
British Journal of Cancer|November 1, 2007
Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancerR K Nam, L Sugar, W Yang, et al.
Prostate Cancer and Prostatic Diseases|September 19, 2007
A genome-wide association screen identifies regions on chromosomes 1q25 and 7p21 as risk loci for sporadic prostate cancerR K Nam, W W Zhang, D A Loblaw, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 10, 2025
A randomized Phase II trial of High Dose-Rate (HDR) and Low Dose-Rate (LDR) brachytherapy as monotherapy in localized prostate cancer: analysis of initial arms of Canadian cancer trials group PR19 (NCT02960087)G Morton, E Vigneault, M Barkati, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Validation of a Metastatic Assay using biopsies to improve risk stratification in patients with prostate cancer treated with radical radiation therapyS Jain, C A Lyons, S M Walker, et al.
Pageof 2